Charleston Laboratories Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Charleston Laboratories General Information

Description

Developer of pain relief medicines designed to treat acute pain and reduce drug- and disease-induced nausea and vomiting. The company develops proprietary drug formulations featuring abuse-deterrent technologies and acetaminophen-free therapies, enabling healthcare providers to deliver effective pain management while reducing the risk of liver injury, misuse, and abuse.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1150 South United States Highway 1
  • Jupiter, FL 33477
  • United States
+1 (561)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1150 South United States Highway 1
  • Jupiter, FL 33477
  • United States
+1 (561)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Charleston Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-May-2026 Completed Clinical Trials - Phase 3
7. Debt - PPP 07-Apr-2020 Completed Clinical Trials - Phase 3
6. Debt - General 25-Aug-2014 Completed Clinical Trials - Phase 3
5. Later Stage VC 06-Aug-2014 Completed Clinical Trials - Phase 3
4. Grant 08-Aug-2013 Completed Clinical Trials - Phase 3
3. Later Stage VC (Series B) 01-Oct-2012 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A) 22-Dec-2009 $975K $1.18M Completed Clinical Trials - Phase 3
1. Early Stage VC 03-Aug-2007 $200K $200K Completed Startup
To view Charleston Laboratories’s complete valuation and funding history, request access »

Charleston Laboratories Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Charleston Laboratories’s complete cap table history, request access »

Charleston Laboratories Patents

Charleston Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170354603-A1 Pharmaceutical compositions Inactive 10-Jun-2016
US-20200054564-A1 Pharmaceutical compositions Inactive 10-Jun-2016
EP-3468558-A1 Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain Inactive 10-Jun-2016
EP-3468558-A4 Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain Inactive 10-Jun-2016
WO-2017214538-A1 Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain Inactive 10-Jun-2016 A61K9/209
To view Charleston Laboratories’s complete patent history, request access »

Charleston Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Charleston Laboratories Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daiichi Sankyo Corporation Minority
To view Charleston Laboratories’s complete investors history, request access »

Charleston Laboratories FAQs

  • When was Charleston Laboratories founded?

    Charleston Laboratories was founded in 2007.

  • Where is Charleston Laboratories headquartered?

    Charleston Laboratories is headquartered in Jupiter, FL.

  • What is the size of Charleston Laboratories?

    Charleston Laboratories has 3 total employees.

  • What industry is Charleston Laboratories in?

    Charleston Laboratories’s primary industry is Drug Discovery.

  • Is Charleston Laboratories a private or public company?

    Charleston Laboratories is a Private company.

  • What is Charleston Laboratories’s current revenue?

    The current revenue for Charleston Laboratories is .

  • How much funding has Charleston Laboratories raised over time?

    Charleston Laboratories has raised $209M.

  • Who are Charleston Laboratories’s investors?

    Daiichi Sankyo has invested in Charleston Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process